Discontinued Operations The summary of the assets and liabilities related to Pharmaceutical Manufacturing- China discontinued operations (Details) (USD $)			12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012 Pharmaceutical Manufacturing - China business [Member]	Nov. 13, 2012 Pharmaceutical Manufacturing - China business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Available-for-sale Securities, Fair Value Disclosure			$ 13,397,900
Noncontrolling interests	(516,040)	(356,970)	6,015,000
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax			4,387,400
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents			8,457,500
Cash and cash equivalents	46,133,759	13,737,452		12,300,000
Restricted cash			2,918,100
Accounts receivable, net			6,130,200
Inventory			15,077,700
Prepaid expenses and other current assets			957,800
Property, plant and equipment, net			38,102,000
Other assets			5,946,300
Total assets		23,800,300
Accounts Payable			(9,604,800)
Accrued liabilities			(2,008,800)
Bank loans			(15,133,500)
Notes payable			(6,599,300)
Unearned revenue			(9,166,800)
Amount due related parties			(7,859,700)
Total Liabilities			27,216,700
Loss on exit of segment			$ (3,416,400)
Treasury Stock, Shares				104,000
Stock Option Cancelled				117,000
Warrants Cancelled				64,000